Ambrisentan for pulmonary arterial hypertension: long term effects on clinical status, exercise capacity and haemodynamics

Int J Cardiol. 2012 Apr 19;156(2):244-5. doi: 10.1016/j.ijcard.2012.01.054. Epub 2012 Feb 12.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Exercise / physiology*
  • Female
  • Follow-Up Studies
  • Hemodynamics / drug effects*
  • Hemodynamics / physiology*
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / physiopathology
  • Male
  • Middle Aged
  • Phenylpropionates / pharmacology
  • Phenylpropionates / therapeutic use*
  • Physical Endurance / drug effects
  • Physical Endurance / physiology
  • Prospective Studies
  • Pyridazines / pharmacology
  • Pyridazines / therapeutic use*
  • Time

Substances

  • Phenylpropionates
  • Pyridazines
  • ambrisentan